Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Elevance Health, Inc. (ELV) had Cost of Goods Sold of $41.08B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$50.18B |
|
$1.76B |
|
|
Cost of Goods Sold |
$41.08B |
$9.10B |
|
$47.52B |
|
$2.66B |
|
$-357.00M |
|
$2.30B |
|
$2.30B |
|
$1.76B |
|
$1.76B |
|
$1.76B |
|
$1.76B |
|
$2.66B |
|
$3.02B |
|
219.80M |
|
220.40M |
|
$8.03 |
|
$8.00 |
|
| Balance Sheet Financials | |
$67.03B |
|
$4.66B |
|
$58.80B |
|
$125.83B |
|
$45.31B |
|
$30.77B |
|
$36.48B |
|
$81.78B |
|
$44.04B |
|
$4.61B |
|
$44.04B |
|
217.37M |
|
| Cash Flow Statement Financials | |
$4.33B |
|
$-1.64B |
|
$-2.52B |
|
$9.49B |
|
$9.66B |
|
$166.00M |
|
$55.00M |
|
$-376.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|